These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8180725)

  • 21. [Double blind randomized comparative study of two antihypertensive combinations. Enalapril-hydrochlorothiazide versus enalapril-nifedipine in 240 hypertensive patients resistant to monotherapy].
    Frances Y; Lafay V; Madona O; Chastang C; Souchet T; Chazelle F
    Therapie; 1996; 51(1):35-9. PubMed ID: 8762218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients.
    Liu L; Zhang Y; Liu G; Li W; Zhang X; Zanchetti A;
    J Hypertens; 2005 Dec; 23(12):2157-72. PubMed ID: 16269957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of dietary fish and weight reduction on ambulatory blood pressure in overweight hypertensives.
    Bao DQ; Mori TA; Burke V; Puddey IB; Beilin LJ
    Hypertension; 1998 Oct; 32(4):710-7. PubMed ID: 9774368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertension.
    Oparil S; Abate N; Chen E; Creager MA; Galet V; Jia G; Julius S; Lerman A; Lyle PA; Pool J; Tershakovec AM
    Curr Med Res Opin; 2008 Apr; 24(4):1101-14. PubMed ID: 18328120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
    Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pilot study of combined blockade of the renin-angiotensin system in essential hypertensive patients.
    Azizi M; Linhart A; Alexander J; Goldberg A; Menten J; Sweet C; Ménard J
    J Hypertens; 2000 Aug; 18(8):1139-47. PubMed ID: 10954007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
    J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive efficacy and tolerability of different drug regimens in isolated systolic hypertension in the elderly.
    Avanzini F; Alli C; Bettelli G; Corso R; Colombo F; Mariotti G; Radice M; Torri V; Tognoni G
    Eur Heart J; 1994 Feb; 15(2):206-12. PubMed ID: 8005121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of nitrendipine and hydrochlorothiazide or metoprolol to treat hypertension in rural community health centers in China.
    Wang Z; Chen Z; Wang X; Hao G; Ma L; Zhao X; Li Y; Zhang L; Zhu M
    J Hypertens; 2017 Apr; 35(4):886-892. PubMed ID: 27977472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Angiotensin-II receptor inhibitors in hemodialysed uremia patients with arterial hypertension: candesartan cilexitil versus losartan].
    Cice G; Ferrara L; Tagliamonte E; Russo PE; Di Benedetto A; Iacono A
    Cardiologia; 1999 Dec; 44(12):1071-6. PubMed ID: 10687258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circadian variation and blood pressure: response to rapid weight loss by hypocaloric hyponatraemic diet in obesity.
    DasGupta P; Brigden G; Ramhamdany E; Lahiri A; Baird IM; Raftery EB
    J Hypertens; 1991 May; 9(5):441-7. PubMed ID: 1649864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of three months' treatment with irbesartan on blood and pulse pressure of hypertensive type 2 diabetic patients: open, observational study in 31,793 patients.
    Strutz F; Bramlage P; Paar WD
    Curr Med Res Opin; 2005 Sep; 21(9):1433-40. PubMed ID: 16197662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: a prespecified subgroup analysis of a community-based, randomized, open-label trial.
    Everett BM; Glynn RJ; Danielson E; Ridker PM;
    Clin Ther; 2008 Apr; 30(4):661-72. PubMed ID: 18498915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistant arterial hypertension and hyperlipidemia: atorvastatin, not vitamin C, for blood pressure control.
    Magen E; Viskoper R; Mishal J; Priluk R; Berezovsky A; Laszt A; London D; Yosefy C
    Isr Med Assoc J; 2004 Dec; 6(12):742-6. PubMed ID: 15609886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Weight reduction versus antihypertensive drug therapy in obese men with high blood pressure: effects upon plasma insulin levels and association with changes in blood pressure and serum lipids.
    Fagerberg B; Berglund A; Andersson OK; Berglund G
    J Hypertens; 1992 Sep; 10(9):1053-61. PubMed ID: 1328365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
    Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
    Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the Efficacy and Safety of the Lercanidipine/Valsartan Combination in Korean Patients With Essential Hypertension Not Adequately Controlled With Lercanidipine Monotherapy: A Randomized, Multicenter, Parallel Design, Phase III Clinical Trial.
    Na SH; Lee HY; Hong Baek S; Jeon HK; Kang JH; Kim YN; Park CG; Ryu JK; Rhee MY; Kim MH; Hong TJ; Choi DJ; Cho SW; Cha DH; Jeon ES; Kim JJ; Shin JH; Park SH; Lee SH; John SH; Shin ES; Kim NH; Lee SY; Kwan J; Jeong MH; Kim SW; Jeong JO; Kim DW; Lee NH; Park WJ; Ahn JC; Won KH; Uk Lee S; Cho JH; Kim SK; Ahn T; Hong S; Yoo SY; Kim SY; Kim BS; Juhn JH; Kim SY; Lee YJ; Oh BH
    Clin Ther; 2015 Aug; 37(8):1726-39. PubMed ID: 26164786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Quality of blood pressure control in general practice and in the HOT study. French Research Group HOT (Hypertension Optimal Treatment)].
    Raveau-Landon C
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1179-81. PubMed ID: 8572869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Nigella sativa Seed Extract for Hypertension in Elderly: a Double-blind, Randomized Controlled Trial.
    Rizka A; Setiati S; Lydia A; Dewiasty E
    Acta Med Indones; 2017 Oct; 49(4):307-313. PubMed ID: 29348380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.